News
Datroway filed for TNBC in EU after data delay
Daiichi Sankyo and AstraZeneca have filed their first marketing application for TROP2-targeting Datroway in triple-negative breast cancer.
News
MSD claims two national priority vouchers; report
The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD drug candidates.
Sales & Marketing
Marketing yourself isn’t selling out. It’s smart science.
The call lasted ten minutes. My manager was apologetic. HR was professional.
News
LIB takes aim at cholesterol market with new PCSK9 option
LIB Therapeutics has won FDA approval for a once-monthly cholesterol drug, Lerochol, that it says offers ease-of-use advantages over rivals.
News
UK, US approve GSK's twice-yearly asthma drug
GSK scores a first approval in the UK for new severe asthma and CRSwNP therapy Exdensur, but a second in the US covers the asthma indication only.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
